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1. Programme purpose and approach  
a. Scope and Objectives  
Neuroimaging has advanced such that functional magnetic resonance imaging can reveal explicitly an 
individual’s thought patterns. This raises ethical and practical questions that society needs to address e.g. 
Who should see our brain images? Should neuroimaging be used as evidence in court, in commerce, or by 
governments? The key objectives of this programme will be to explore the ethical impact of neuroimaging 
on society. By stimulating debate and gathering opinion between the general public, societal groups 
(patients, prisoners), scientists, clinicians, ethicists, legal experts and politicians, we will raise awareness of 
privacy and ethical issues, determine a cross-section of opinion, and through engagement of users and 
policy makers, publish reports to guide policy outcomes.  
b. Main questions to be addressed 
1. Who should see our brain images?  
2. Should neuroimaging be used as evidence in court (neurolaw)? 
3. Should neuroimaging be used in commerce  
4. How do different sectors view neuromarketing? 
5. Should neuroimaging be used by governments? 
6. Should there be a code of practice to guide neuroimaging uses in some sectors? 
7. Should users/providers be licensed? 
These questions challenge conventional thinking. Neuroimaging is advancing so rapidly that most sectors of 
society have not realized its full capabilities, applications and implications (some potentially sinister). The 
serious privacy and ethical issues have not been debated, particularly across a wide range of sectors. 
c. Main Aims  
This programme aimed to develop a community for debate including academics, government, legal 
professions, ethicists and the lay public, in order to understand how sections of society perceive and react 
to the implications arising from advances in neuroimaging. The programme aims; firstly, to understand the 
context in which neuroimaging has begun to influence different sectors of society, in particular its use in 
law and in neuromarketing; secondly to study the legal and human rights implications of these uses; and 
thirdly to consider what constitutes acceptable practice, and whether and how this should be regulated.  
d. Format and structure  
The programme consisted of two two-day workshops and a third workshop over three days, each with 
national and international speakers and between 30 and 40 participants, a longitudinal work package, 
ending in a presentation to the Scottish Parliament: 
i. Part 1: Advances in Neuroimaging and the implications for society  
A 2-day workshop (6th-7th May 2010) primarily addressing questions 1-3 above. The workshop covered what 
is currently possible using brain imaging and debated whether and how brain imaging is appropriately used 
in legal and marketing contexts. The workshop covered current capabilities and future projected 
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developments in functional and structural magnetic resonance imaging (MRI), magnetoencephalography 
(MEG) and molecular imaging methods as applied to legal and forensic use [1,2]; determining moral intent 
[3]; mind reading, lie detection [4,5]; neuromarketing [6]; the limitations of brain imaging [7]; data 
management issues including storage, access to brain images for research or clinical purposes, image 
ownership and privacy. Topics included the blurred boundaries between science and commerce and the 
potentially subliminal use of brain imaging research for economic gain [8,9,10].  
ii. Part 2: What is the legal view; forensic uses of neuroimaging, ethical considerations, 
security, privacy and human rights  
A 2 day workshop (7th-8th June) focused on uses of brain imaging in law. Speakers included Prof Hank 
Greely, Prof of Law at Stanford, and Judge Jed Rakoff, Senior Judge from the State of New York.[11] The 
participants discussed whether it was appropriate to use brain imaging for lie detection, moral intent, 
establishing criminal responsibility, in the penal system, discussed exemplar court cases and in what if any 
circumstances might it be appropriate to use brain imaging in law.[12,13] The need for regulation of 
forensic technologies was discussed. Six key points were addressed: 1) is the technology reliable enough to 
support legal decision making? 2) Does it answer the questions the law asks, or is there a conceptual 
mismatch? 3) How do the answers to 1 and 2 influence the boundaries between legal and medical 
intervention? 4) Can the science (and its limitations) be reliably communicated to the legal profession 
(judge, jury or probation officer)?[14] 5) If punishment is based on this technology, can this be presented so 
as to avoid loss of respect for the legal system by the general public? 6) Are there any legal reasons why the 
technology should not be used even if the answers to all these questions are yes?  
iii. Part 3: Influencing policy, Discussion of ethical guidance and practice  
Scotland’s Futures Forum (SFF), a non party-political organisation owned by the Scottish Parliament’s 
Corporate Body, co-ordinated the third workshop in two parts, the first for the lay public in a World Café 
style debate and the second for policy makers, culminating in a presentation to MSPs at Holyrood. Event 1: 
on 25th June included 45 lay members of the Forum who heard a summary of outputs from the two prior 
workshops, debated key topics, considered exemplar court cases, and provided feedback. Event 2: on 19th 
August, assisted by the Scottish Government’s Chief Scientist’s organisational networks and attended by 
Prof Anne Glover Chief Scientific Advisor, included 50 policy makers. Professor Jonathan Moreno, expert in 
biomedical ethics, advisor to the White House Office of Science and Technology Policy, co-chairman of the 
Committee on Guidelines for Human Embryonic Stem Cell Research in the USA, provided an international 
perspective. Debate focused on any requirement for regulation, other methods of encouraging public 
awareness and ways to engage Government. A summary of the conclusions from all three workshops was 
presented to MSPs at Holyrood (Event 3) on 29th Sept. The presentation was attended by the shadow 
Education Minister, a member of the Health Committee and researchers. It was preceded by a publication 
in the journal Holyrood on brain imaging. 
iv. Part 4: Longitudinal Work Package  
The workshops were underpinned by a substantial amount of background work including an extensive 
survey of media representations of neuroimaging culminating in a systematic review of uses of imaging 
outside traditional medical diagnosis or scientific research, creation of multiple summary posters, several 
interviews with science journalists (eg Holyrood, the Glasgow Herald, BBC Scotland). An online survey was 
designed using ‘Survey Monkey’ to obtain the opinions of non-expert members of the public and those with 
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expertise in neuroimaging on wider uses of neuroimaging and whether it should be regulated. The surveys 
targeted the public and neuroimaging experts (e.g. psychologists, radiologists, neuroscientists), through 
dissemination in the media, professional society circulation lists, organizations like Beltane, and websites 
(SINAPSE, Edinburgh Neuroscience, SCRIPT, Joseph Bell Centre (JBC), Futures Forum), science blogs and 
other websites. The survey ran from the 2nd workshop until 30th Sept 2010. 
e. References 
1. Aggarwal N.K. J Am Acad Psychiatry Law 37:239–44, 2009; 
2. Batts S. Behav. Sci. Law 27: 261–272 (2009); 
3. Harenski, C.L., doi:10.1016/j.neuroimage.2009.10.062; 
4. Langleben D.D. J Am Acad Psychiatry Law 36:502–4, 2008;  
5. Simpson J.R. J Am Acad Psychiatry Law 36:491–8, 2008; 
6. Lee N. International Journal of Psychophysiology 63 (2007) 199–204; 
7. Martell D. Behav. Sci. Law 27: 123–136 (2009). 
8. Neuromarketing: Companies Use Neuroscience for Consumer Insights, Laurie Burkitt, 10.29.09, 02:00 PM 
EDT, Forbes Magazine dated November 16, 2009; 
9. Neuromarketing and consumer free will, Journal of Consumer Affairs, Fall, 2008 by R. Mark; 
10. http://neuromarketing.ning.com/; 
11. Complex Brain Imaging Is Making Waves in Court, Publication Date: October 17, 2008, Source: San 
Francisco Chronicle, Author: Reyhan Harmanci also at http://storybank.stanford.edu/stories/complex-
brain-imaging-making-waves-court; 
12. Brain Imaging and Criminal Law, May 04, 2009, by Astrid Fiano, DOTmed News Writer; 
13. The court will now call its expert witness: the brain. November 20, 2009 by Ingfei Chen, 
 http://www.physorg.com/news177927125.html.  
14. House of Lords (HoL) ”Forensic Science on Trial” 2005. 
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2. Outputs and outcomes 
a. Areas of thinking explored in each section of the programme and key 
points emerging 
i. Workshop 1. Imaging: Advances in Neuroimaging and the Implications for Society 
Forty neuroradiologists, neurologists, neuroscientists, psychologists, psychiatrists, physicists, lawyers, 
ethicists, political scientists, philosophers, social scientists, science journalists and imaging and law students 
met for the first of a series of workshops, to discuss the emerging wider societal implications of brain 
imaging. After two days of expert talks, panel question and answer sessions, discussion groups and 
feedback, the main conclusions of the group were as follows. 
1. Although neuroimaging techniques are already in use in law, marketing and are being considered for 
use in public security, this is at present without a secure scientific foundation. Since the potential 
applications, implications and economic impact of neuroimaging are so substantial, they mandate:  
a) an informed public debate and  
b) further research to underpin these wider uses. 
2. The group expressed concern about the increasing use of neuroimaging techniques, particularly 
functional neuroimaging, as evidence in a court of law, in marketing or in public security. However, the 
neuroimaging scientists and clinical academics recognise that the increasing use of these techniques is 
simply a consequence of the need for improved assessment methods in these sectors. 
3. Diffusion of neuroimaging into areas beyond basic science (e.g. law, marketing, public security) 
indicates a need for increased research and greater academic engagement to ensure that the methods 
and interpretation are fit for purpose in these new settings. 
4. The tendency to extrapolate the results of neuroimaging research well beyond the subject group or 
setting in which they were originally derived is potentially harmful both to the original research and to 
the groups or individuals to which the data might be applied.  
5. There are many – often not well understood – implications involved when extrapolating from data 
derived from research studies obtained in groups of participants in focused traditional neuroscience 
research settings, to imaging results obtained from a single individual in a setting that may be very 
different to the original research environment. 
6. It is important to make sure that the results of scientific research are applied correctly when applied in 
a new field. One must take account of the population and setting in which the research was originally 
conducted. So, the interpretation for a test designed to be performed in a psychology laboratory 
environment would be very different if the test was to be undertaken in a different setting or its results 
applied for other purposed (e.g. legal or security).  
7. Much larger amounts of normative data, from both structural and functional neuroimaging across 
people from many backgrounds, ages and cultures are required, both  
a) to enhance understanding of research outputs of neuroimaging and,  
b) to inform its wider use outside the traditional research fields by other sectors. 
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8. Neuroimaging scientists should both strive to build databanks of normal data from data already 
collected and ensure that future collection of imaging data from normal subjects can be added to such 
normative image banks to inform future research. 
9. Those involved in the conduct of neuroimaging research in academic science environments should 
recognise that the results expressed as an image can be highly compelling and may be 
disproportionately persuasive compared with other forms of evidence. They should be cautious in how 
they communicate the results of their research both to peers, the media and the public to avoid being 
the source of unreasonably positive or negative messages.  
10.  Those involved in the conduct of neuroimaging research in academic and science environments should 
be aware of the inherent conflict of interest between the need to publish high-quality research, achieve 
high academic impact, the increasing pressure to have a media presence, and the risk that these 
pressures will distort the interpretation of their research results.  
11.  Communication between the different sectors and stakeholders involved in using neuroimaging 
technologies is poor and needs to be improved. Equally, communication of results of neuroimaging 
research by neuroimaging researchers to the media, and in turn by the media to the public, needs to be 
improved.  
12. Media communication should be improved specifically: 
a) To give the public greater objectivity in interpreting information provided in the media, 
b) To improve objectivity in assessment of imaging as evidence in any context,  
c) To be clearer about what the results of imaging add to existing assessment tools, for example, to a 
range of different forms of evidence that might be provided in court or a range of market assessment 
tools. 
13.  Guidance for conduct and presentation of neuroimaging, particularly functional neuroimaging, 
experiments such as are available for other forms of research (see EQUATOR Network, 
http://www.equator-network.org/) would be valuable and could help avoid many of the 
methodological errors and consequent biased assessment of the value of some neuroimaging 
experiments in the past.  
14.  Given that neuroimaging is a rapidly advancing and complex field, neuroimaging scientists should be 
aware of and open to re-evaluation of previous results, consideration of adoption of new research 
designs, and be open to radically new interpretations that may mean that prior understanding of 
neuroimaging data is shown to be seriously flawed. 
ii. Workshop 2: Law. What is the Legal View? 
Thirty-seven lawyers, judges, philosophers, political scientists, Church representatives, sociologists, 
neuroradiologists, neurologists, neuroscientists, psychologists and bioethicists met for the second part of 
the debate on Brain Imaging and its Impact on Society, “What are we thinking? Who has the right to 
know?” After two days of expert talks, panel question and answer sessions, consideration of four exemplar 
court cases, discussion groups and exercises to construct a series of frequently asked questions for lawyers 
and neuroscientists, the main conclusions of the group were as follows.  
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1. Because of the importance of mental states in defining criminal offences and defences, from the all 
important concept of intent to the insanity defence, the temptation to use results from neuroscience in 
a legal context will be high. While the issue of establishing actus reus, the factual aspect of a crime, has 
profited on a massive scale from modern science such as DNA, proving the mental element of an 
offence has remained as difficult as it was in the 19th century. The mere promise of addressing this 
difficulty is likely to put pressure on substantive and procedural criminal law, as already seen in other 
jurisdictions. 
2. The continuing reliance on eyewitness evidence and confessions, despite the increasing recognition of 
their unreliability, will put further pressure on using a “technological fix” that could give these ancient 
forms of evidence a modern, scientific seal of approval. 
3. There was strong consensus that attempts to replace core legal concepts such as intent by 
neuroscience based vocabulary as is discussed in several continental European jurisdictions in 
particular, let alone giving up the notion of personal responsibility or free decision making on which the 
criminal law depends, are very premature. There is no strong scientific case to be made at this point in 
time to require revisiting these concepts, and there are some good methodological and philosophical 
reasons why even further progress in science is unlikely to change this assessment. Misrepresentation 
in the media needs to be addressed not just by scientists, but also lawyers and philosophers that can 
communicate the difference between legal and scientific notions of intentional decision making.  
4. There was general consensus among the legal professionals present that there is at present little place 
for use of brain imaging in court to establish a diagnosis of mental illness, for lie detection, to 
determine intent, personal preferences or behavioral traits. While neuroscience has made impressive 
progress in some of these fields (and in some much more than in others) the prejudicial effect on the 
jury is too high, and the difficulties to quantify the reliability too serious. The last point is worth 
emphasising – we need to know not just the positive results that have been achieved, but also the 
limitations and failures of the technology. 
5. More generally, there is a danger that an “illusion of knowledge” is created with little guidance or 
insights into how to use this knowledge responsibly, or indeed what to do with it at all. This is 
potentially dangerous for public discourses about risks, such as the risk of (re)offending, the risk to 
suffer from an illness, etc.  
6. There is a risk that results are used that have little to no ecological validity in forensic settings. Results 
achieved with very limited sample size, and from non-random populations (typically students) may not 
be valid in the general population, or the subsection most likely to come into contact with the legal 
system.  
7. The use of images in addition carries the risk of being prejudicial when used in front of a lay jury who 
lack scientific training, and to distort the true evidential value. At present, expert witnesses testifying 
on court are mainly traditional scientists with little or no dedicated forensic training. Dedicated forensic 
research, and training into appropriate and law-compliant communication of these results, is needed. 
Equally needed are standards for the presentation of evidence, such as uniform colour schemes – we 
recommend indeed not to use the images at all and rely solely on verbal statements, but this requires 
further research. 
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8. The experience from the US indicates that a principled approach to the admissibility of evidence 
provides some efficient safeguards, but also shows that commercial operators of debatable quality will 
soon become active in legal fields such as employment disputes or criminal sentencing/parole board 
decisions, etc, where these safeguards do not apply. 
9. For the UK, reviving the idea of a "Forensic Science Advisory Council" as suggested by the “Forensic 
Science on Trial Report” by the House of Commons Select Committee, to act as gatekeeper for new 
types of evidence would be a useful approach also to inform on areas of neuroscientific evidence, but 
also on other emerging areas of science that face similar issues. Great care needs to be taken that less 
regulated fields of legal decision making such as civil procedure, or in a criminal setting, sentencing and 
bail decisions, do not become “beachheads” for the use of neuroscience. For this reason, reviving the 
FSAC model is likely to be more efficient than adopting the US Daubert criteria for admissibility of 
expert evidence, which would only regulate criminal trials.  
10. Learning from the experience in computer forensics regarding e.g. standardisation of tools and 
equipment would be beneficial, as would be standards for presenting neuroscientific evidence in court. 
Neuroimaging is an interdisciplinary field, and an appropriate professional body for accreditation of 
experts need to be found – a problem also faced in other disciplines., indicating the need for a 
regulation of forensic scientists qua forensic scientists, outside and in addition to their “home 
disciplines”. 
11. In addition to the reliability of the evidence, other factors also need to be taken into consideration, in 
particular privacy concerns - this debate is in its infancy so far in the US and UK, but more developed in 
Germany and Spain. There, the use of neuroimaging for lie detection is deemed a violation of human 
rights to both privacy and a fair trial, a position that may well also be taken by the European Court of 
Human Rights. In the UK, the right against self-incrimination also needs to be explored in relation to 
fMRI. 
12. Privacy issues also need to be addressed when it comes to storage and handling of brain images, and 
their potentially biometric nature needs to be taken into account when developing privacy law 
compliant regimes. Since it Is possible from the image of the brain folds to uniquely identify a person, 
they are personal information under data Protection law. Great care has to be taken to protect privacy 
while at the same time permitting important research to continue, and legislative action may be 
needed to permit researchers to conduct studies without fear.   
13. Analogous application of the Human Tissue Act, or an explicit extension of the provision of this act to 
brain images, needs to be discussed. 
14. Reuse and third party use of results from both research and forensic cases, especially by insurance 
companies, needs to be examined. A moratorium along the lines of the moratorium on use of DNA 
results by insurance companies might require discussion. Volunteers for research, or people willing to 
undergo scans in a legal setting, should not suffer detriments when incidental findings also show health 
issues. 
15. Despite these concerns, care also needs to be taken not to use overly restrictive regulation as this 
might regulate inappropriately for use of imaging in the wider context, for example. 
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16. Informed public and professional debate will be important to encourage society to consider the 
implications and ensure that any future regulation would be evidence-based. 
17. There is significant need to ensure that the public is informed about the limitations and implications of 
brain imaging both in medical practice, neuroscience research and any possible wider uses. 
18. There is a need for more research into the wider uses of brain imaging, in particular from a neuroethics 
perspective. The group noted examples of national funding for enhancing the neuroethics debate in 
some countries, such as the Canadian Neuroethics Network, and agreed that this was an exemplary 
approach. 
19. Neuroscience and neuroimaging can play a more prominent role in societal and sociological research, 
for example in longitudinal studies of development, so that neuroscience can contribute to our wider 
understanding of brain function – society interactions. 
20. Communication between researchers across disciplines to remove interdisciplinary barriers should be 
strongly encouraged. This would be facilitated by strategically placed interdisciplinary PhDs or post-
docs jointly hosted, for example, in law and neuroimaging. 
21. Information concerning neuroscience and forensic uses of imaging should be incorporated into training 
of lawyers even if only on a minimalist basis given the already full timetable. The Judicial Studies Board 
or possibly the Law Commission should be encouraged to consider inclusion of forensic uses of 
neuroimaging as part of their CPD offerings, or as part of the undergraduate legal curriculum where 
there is an increasing need for introductory courses in forensic sciences in general.  
22. Neuroimaging scientists should be encouraged to speak to the media to help improve public 
understanding and awareness, but need to be aware of the wider philosophical and societal issues their 
findings can trigger. Interdisciplinary training for science communication is necessary 
23. Potential implications of licensing of fMRI operators should be explored. Experience from the US shows 
that companies with sometimes problematic track record and approaches are likely to offer services 
targeted for legal use (e.g. employment issues) which could also increase the pressure on the legal aid 
budget.  
24. Consideration should be given to the implications of regulating non-medical uses of neuroimaging, 
including possible health effects of reiterated screening (e.g. when screening is used for mortgage 
applications).  
25. The formation of normative banks of neuroimaging data should be encouraged. Benchmarks of this 
type are also important to be able to report error bars, as is increasingly required by courts when 
dealing with expert evidence, and a foral requirement in the US under the Daubert criteria.  
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iii. Workshop 3, Part A.  Members of the public: Summary of main points raised by 
members of the public participating  
26 members of the public from the Futures Forum with five representatives of imaging experts and the 
organisers of Futures Forum met at the Institute of Advanced Studies, University of Strathclyde, Glasgow on 
Friday 25th June 2010 to discuss brain imaging and its impact on society. 
Several themes emerged from discussions during the course of the day and during the final feedback 
sessions. 
Distinguishing between different uses of imaging 
Participants felt that it was important to distinguish different uses of imaging, as these represented 
different levels of acceptability and any need for additional regulation. Thus, the participants were 
unanimous about the benefits of imaging used in medical practice where there were clear benefits to the 
individual as well as to society. The use in research, which might not benefit the individual but in the long-
term would hopefully benefit society, was already addressed by research ethics committees. Beyond that 
the benefits both to the individual and society were much less clear cut, e.g. where someone pays because 
they want to have a scan, in commercial or some legal uses. Finally, there would be a situation where an 
individual could be forced to have a scan, such as for security, in the penal system or for legal reasons. 
Regulation 
1. Regulation of imaging technology when applied outside medicine was considered to be key and 
participants were keen to talk to government concerning this. They saw a government role as key and 
welcomed the role of Parliament but acknowledged that all governments would need to move in the 
same direction towards a regulatory framework, not just Scotland. 
2. There was strong advocacy for a regulatory body covering use of forensic evidence, including imaging, 
such as was proposed for the Forensic Science Advisory Committee. 
3. In many circumstances there were already regulations which, if applied appropriately, would cover use 
of imaging outside medicine and ethically regulated research. 
4. If politicians were to ensure that existing legislation regarding assessment of employees were enforced, 
then any use of imaging under those circumstances would probably not be allowed and therefore the 
regulation of use of imaging by employers would probably not require new legislation. A change in 
technology from some older method to imaging does not alter the principle that lie detection or other 
forms of assessment with imaging is wrong at interview. 
5. There was scepticism concerning the motives of large commercial organisations with interests primarily 
focused on profit and was little confidence in industry self-regulation or transparency of techniques. 
6. Use of imaging should be heavily regulated to prevent use of data in unregulated ways. This would 
include greater regulation of retention of employment records (currently voluntary) and transparency 
of access and usage. 
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The need for expert knowledge 
1. A scan was seen as a snapshot or photograph and somewhat meaningless without expert 
interpretation. 
2. Images were recognised to be more compelling than traditional verbal descriptions of evidence and as 
such needed to be used cautiously. 
3. If images were to be used in court, then this should only be with expert interpretation and with 
guidance from the judge to the jury on how to use the information given. 
4. There was considerable cynicism regarding the ‘social’ uses of imaging and it was recognised that it was 
important to understand the subject very well in order to avoid advancing in the dark in these areas. 
Imaging seen as being no different to other forensic technologies 
1. Imaging was seen as a psychometric tool, and little different to other technologies used for similar 
psychometric purposes such as lie detection or detecting personal preferences, and therefore should 
be regulated just like any other psychometric tool.  
2. As regards use of imaging in marketing or industry, the group was not convinced that imaging was any 
different to any other forms of subliminal marketing that were already regulated. 
3. Use of imaging, e.g. as part of employment assessment, raised of a number of complex issues, not least 
of which were potential infringements of disability laws and civil rights, both of which were already 
covered by existing regulatory frameworks. In the case of employers using lie detection equipment, the 
group recognised that in some jobs, lying could actually be regarded as a good attribute! It was felt to 
be narrow-minded and short-sighted of employers to use scanning in place of taking account of the 
individual’s background, experience, performance at interview or references. 
4. It was recognised that the results of a functional imaging study obtained from the same person could 
be very different in different contexts and depend on cultural interpretation, mood-related factors and 
change over time. Overzealous usage of such techniques, without due regard to context and awareness 
of reliability of evidence, might result in adverse labelling of subjects which would be difficult to shake 
off and could result in significant disadvantage to the individual depending on the societal morality and 
cultural contexts. 
Wider understanding of imaging science 
1. There is a need for more qualified scientists to work as journalists and for more scientists to participate 
in government. 
2. Politicians need greater understanding of technologies, not just imaging. 
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iv. Workshop 3, Part B: Main outputs of the policy makers discussion  
Policymakers and representatives from key governmental and professional organizations met to hear and 
discuss the main conclusions of the previous three meetings. The main points arising were as follows.  
Searching for principles 
Much of the discussion concerned concepts of cognitive liberty, who has or should have access to an 
individual’s personal thoughts and issues of self incrimination should thoughts be accessed inappropriately.  
1. It was recognised that neuroimaging had the potential to intrude on individuals’ thoughts, but it was 
unclear as to how far science should go, where to draw the line, and that there are some questions that 
we should not ask even if the technology is capable of addressing these. 
2. The point was made that live dissection is not and has not for many decades been considered 
acceptable in a law-abiding civil society, so why should we allow mental dissection? This has parallels 
with legal standards which say that evidence obtained by torture, no matter what the pretext, is 
unreliable, offensive and inadmissible in court. 
3. There was a sense that the use of neuroimaging technology outside of medicine or rigorous scientific 
research should be “parked for a decade” for understanding to mature and society to catch up with 
understanding implications of potential uses. 
Need for regulation of neuroimaging uses 
1. There are currently no regulations to guide how expert witnesses should be selected. Expert witnesses 
may not be adequately qualified to comment on specific forms of forensic evidence in court. Minimum 
standards for expert witnesses to act in the field of neuroimaging (as well as other forensic 
technologies) should be established.  
2. Admission of forensic evidence in court is not based on any standard at present in the UK, although 
there are standards in other countries. The Governments should be encouraged to implement a 
Forensic Science Advisory Committee, as suggested in a previous House of Commons Select Committee 
report. 
3. A watchdog to monitor commercial and “direct to consumer” uses of neuroimaging should also be 
considered as these uses would not be covered by a forensic committee and a watchdog approach 
would be more relevant to non-traditional uses of neuroimaging to which the general public might be 
exposed. 
Interdisciplinary working 
1. Scientific literacy amongst many sectors of society, including lawyers and politicians, is poor even 
though society is totally dependent on science and technology. Most science and technology is invisible 
to the public and many may not be very interested. 
2. There is a clear need for more integrated working at all levels of training between medical and scientific 
researchers and lawyers and policy makers. This would enable the researchers to direct their science 
towards questions that are raised on uses of neuroimaging in legal/forensic situations.  
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3. Some caution would be required as to how this would be achieved to ensure that appropriate research 
is supported and avoid the pitfall of “reindeer science” (if you fund research on reindeer then many 
groups will start making their research relevant to reindeer). 
Scepticism should not impede valuable medical and scientific progress 
1. Scientific progress is a fact of life and society should aim to benefit from the advances while not 
suffering from adverse consequences. 
2. Prohibition rarely works and could impede important scientific progress. 
3. Communication of capabilities/risks of neuroimaging to society is essential. Neuroimaging could learn 
from other technologies as to good and bad ways of achieving optimum communication. 
Policy 
1. In forming policy, evidence is often ignored and there may be a lack of transparency. Policy may be 
driven by popular opinion/perception rather than evidence. 
2. Few scientists enter politics, few special advisors or politicians or civil servants have a scientific 
background and few have any training in how or where to obtain objective and balanced information 
when they require to do so. And may resort to contacting a colleague who they think might have some 
relevant knowledge (a haphazard approach).  
3. It is difficult for scientists to engage in the formation of policy as there are few channels for 
representation and scientists/medical experts may be seen as “remote” and “hard to understand”.  
4. Scientists/medics should take more interest in engaging with politicians at all levels. Mechanisms 
include student/early post doc exchanges with government research offices, through to easy 
availability for expert advisory groups. 
5. Principles to help engage politicians in having greater awareness of the implications of neuroimaging 
and in forming any guidance are likely to include ways in which neuroimaging might impact on 
formation of a fairer, safer, society and efforts to increase accessibility to expert scientists and medics.  
v. Workshop 3. Part C. Scottish Parliament: MSPs and government researchers 
presentation 
Twenty-one participants from the earlier workshops attended the Scottish Parliament at Holyrood and 
presented a summary of thinking to date at a lunchtime meeting. The meeting was attended by two MSPs 
(Shadow Education Minister and member of Health Committee), several researchers and committee 
representatives (the attendance was less than anticipated due to late running sessions). 
MSPs and researchers were clearly interested in the topic and concerned about how to take this forward. 
There was discussion of self regulation (about setting standards) versus state regulation (control of specific 
uses) with analogies to other technologies such as DNA and fingerprinting; about differences between the 
Scottish and Westminster legal systems that might have impact on this topic; safety aspects of scanning 
outside medical environments; other options for raising awareness amongst MSPs and civil servants and for 
determining the level of any government input/control. 
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There was interest in spreading awareness of issues raised by the programme through a range of 
mechanisms including:  
1. Discussion in the annual debate on Science; 
2. A member’s debate; 
3. Presentations to committees including Justice, Health, and Science and Technology; 
4. Tabling of Parliamentary Questions, for example, a question to the Justice Minister might be “What 
consideration has the Minister given to the regulation of brain imaging in non-medical settings?”  
5. Presenting to the Scottish Science Advisory Committee; 
6. Secondments of up to two to three months for PhDs or post-docs into Parliament would be valuable, an 
outcome that had already been suggested in the Workshops.  
b. Background work package: Online survey 
Two surveys were designed to obtain as broad as possible a sample of public and expert opinion on wider 
uses of neuroimaging. A prototype survey was designed and tested internally and reviewed at the first 
workshop. Changes were adopted and the surveys went live in early June 2010.  
The following is a snapshot of the responses to the survey as at 24th October 2010. Final results are unlikely 
to change materially.  
i. Survey of public opinions 
Six hundred and fifty five subjects responded. The majority thought that neuroimaging was able to 
diagnose neurological diseases such as tumours, but probably was not able to identify consumer 



















Public survey: How well do you think Brain 
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Most respondents were happy for their neuroimaging to be used for scientific or medical research, but less 










































Public survey: Would you be comfortable 


























If Bra in Ima g ing  is  use d  fo r the  p urp o se s a b o ve , ho w co nce rne d  




























































































































Brain Imaging: Programme Report 
15 
 
Most respondents thought that regulation was a good idea but did not favour self regulation by researchers 
or by licensing of imaging centres. Rather, there was a preference for regulation by professional 





















ii. Survey of “Expert” opinions  
303 individuals responded to the Expert Survey. Approximately equal thirds had <5 years, 5-10 years or 10-
20 years experience with neuroimaging. The majority of respondents in the Expert Survey report using 
neuroimaging for neuroscience research (65%), followed by clinical research (47%), medical diagnosis 
(35%), neuromarketing (4%), for forensic purposes (4%) and for security purposes (1%). 
Most respondents were aware of the use of neuroimaging outside traditional research (84%), particular for 
neuromarketing (56%) and lie-detection (57%). Moderate levels were reported for legal uses (41%), 
neuroaesthetics (47%), cognitive enhancement (47%) and mind reading (39%). Little awareness was 
reported for security purposes (9%).  
Respondents had little awareness of how frequently neuroimaging had been used in court in the USA, most 
estimating no more than 30 times in the last five years.  
Most felt that professional guidelines were the best strategy for regulating uses of neuroimaging (37%), 
then professional guidelines (36%), improved public awareness (25%) and funding for interdisciplinary 
projects integrating neuroscience and law (24%). 64% fear the over regulation of neuroimaging in research. 
There was strong support for public education (76%), interdisciplinary projects (71%), and professional 
guidelines (70%).  
If you feel that brain imaging should be 
regulated to protect the public from its 
potential misuse, then how do you feel that 
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Although most respondents believed it was important to communicate their results to the public (67%), 
most said that they do not regularly engage with the media (51%), citing little opportunity (66%), little 
incentive (40%) and distrust of media (29%) as their main reasons, followed by a lack of public speaking 
training (16%) and a fear of criticism (6%). When asked how this situation might be improved, the majority 
rated as quite or very effective professional credit for public engagement (70%), funding requirements 
(57%) and public exposure of research (71%), followed by outlets for a career in media (24%).  
Most (82%) felt that neuroimaging was not accurately portrayed in the media, the main reason given being 
poor journalism (54%), followed by exaggerated results by researchers (43%), a lack of effective scientific 
communication (31%) and poorly conducted research (36%). Although many believed that increased 
exposure to neuroimaging research will raise its public profile as a beneficial technology (90%), 75% 
foresaw a public backlash to the widespread use of the technology. 
iii. Commentary from independent researcher given access to the project (O. Escobar) 
Scientific communities and policy networks around the UK have come to recognise the importance of 
fostering ‘upstream public engagement’, that is, early public dialogue around potentially controversial 
scientific advances. It is said that upstream engagement allows for substantial reflection and discussion, 
and thus contributes to avoiding the kind of public outrage and media misrepresentation that has 
jeopardised other research agendas in the past.  
Both popular media and research literature have provided countless accounts of the reactive modus 
operandi that often characterises scientific and policy communities when it comes to potentially 
controversial science. Scientific communities have been accused of lack of transparency and accountability 
to the public, as well as of being so immersed in their own research agendas that they ignore the wider 
societal impact of their work. Policy-making bodies, in turn, have been accused of lacking in capacity to 
anticipate scientific controversies before they explode in the public media, when it is already too late to do 
anything but swimming with the tide of public opinion. 
The Brain Imaging Dialogue represents, at least in part, an example of a substantially different approach. 
Here we find a scientific community that, in the face of increasing internal concerns, decides to take a 
proactive role. In cases like this, there are always various options on how to go about it. The most common 
way of operating is to assemble a small group of elite experts charged with the task of giving a verdict on 
the subject in order to inform policy. This is the classic technocratic approach to informing policy making. 
However, this canon of practice is widely criticised, and the critique has also been taken on board during 
the last decade by policy networks and research funders alike. The alternative seems to be to move 
towards more participatory approaches, whereby broader networks are included in dialogue processes. 
Such dialogue processes are now often encouraged, if not mandated, by research funders. This is done 
mostly through grant application requirements to estipulate what sort of public engagement a research 
team is planning to do as part of a new project. In some scientific communities, this requirement is 
increasingly seen as an imposition, a sort of permanent duty to renegotiate their ‘license to practice’. Some 
researchers within Science and Technology Studies have criticised this top-down approach to mandating 
public engagement, because too often it seems to work out in detriment of the quality of such dialogue 
processes. Accordingly, some commentators are advocating instead for more genuine bottom-up 
initiatives. 
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The Brain Imaging Dialogue represents an example of one such bottom-up initiative. It is the case of a 
scientific community –a Scottish neuroimaging network- that takes a proactive stand in the face of their 
concerns regarding non-medical uses of Brain Imaging Technologies. Instead of simply looking inwards, 
assembling a group of elite neuroscientists and adopting a traditional lobbying approach, the project 
initiators looked outwards and aimed at bringing together cross-disciplinary voices and stakeholder views in 
a complex dialogue process. In order to do so, the organisers sought ad hoc funding. In other words, they 
did not have to do it; it was not a mandated, but rather a proactive and inclusive move. 
The length, breadth, and depth of this dialogue process are described elsewhere in this report. In addition, 
further independent analysis of the process itself, as a participative and deliberative project, is also being 
undertaken beyond this report. For the purposes of this section, however, it is important to highlight the 
innovative nature of the project. Instances of scientific communities engaging widely with other disciplines 
and publics are rare. The organisers of the Brain Imaging Dialogue recognised from the outset that their 
issues and concerns have wide ethical, social and political implications. They acted accordingly, creating a 
broad platform that included both experts and non-experts in order to look at the issues from a variety of 
perspectives.  
Taking such a collaborative, interdisciplinary, and participative approach is far from being the easy option. It 
presented many challenges, for instance, regarding the difficulty of communicating across disciplinary, 
ethical and epistemological divides. That is, across different ways of understanding, judging, and expressing 
the complexity of the issues at stake; issues that are typically characterised by the entwinement of facts 
and values. Nevertheless, the process also presented well-accomplished opportunities. In particular, it 
created a safe space for informed and open dialogue and deliberation, that is, a space free from the rush 
and superficiality that too often characterise media and political debate. All in all, the process represented 
a departure from the well-known frameworks epitomised in the expressions ‘science for society’ and 
‘science in society’, and a move towards more innovative and integral approaches to ‘science with society’. 
When it comes to science and technology, being proactive in terms of public engagement is ever more 
encouraged by policy making and research funding bodies. Yet, it remains to be seen whether the outputs 
from this kind of upstream engagement are actually taken seriously in decision-making arenas. Otherwise, 
there is not much point in having proactive and publicly engaged scientific communities, if policy-making 
bodies are to remain reactive when it comes to potentially controversial science. To be sure, this does not 
mean that decisions should or could be made based uniquely on a dialogue process, no matter how 
ambitious or comprehensive it was. What it means is that processes like the Brain Imaging Dialogue provide 
the necessary groundwork to enable further policy deliberation to get under way timely, rather than 
reactively. 
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c. Summary of issues and thinking from the programme as a whole  
The overarching principles that emerged during the workshops were that evolving technology is a fact of 
life and that, like a language, technology is a living changing entity that evolves through interactions with 
society. We should try to reap the benefits of the best aspects of new technologies while not falling foul of 
the problems or suffering inadvertently from the adverse effects on society. 
1. The overwhelming conclusion from medical, scientific and legal experts, and informed members of the 
public, was that there was little scientific validity for current use of imaging in law, commerce or 
security.  
2. However, the workshop participants all recognised that the increasing use of imaging in these areas 
was simply an indication that the forensic, commercial and security sectors felt the need for improved 
methods to determine the validity of evidence, consumer preferences, etc. 
3. Lawyers, medics, scientists need to talk to each other more to make sure that new technologies are 
used appropriately. 
4. More cross-disciplinary research at the interface between imaging and law, government and commerce 
is required to ensure that new technologies are used appropriately.  
5. Guidance for conduct and presentation of neuroimaging data to help standardise content of articles, as 
for other types of research study, would be valuable. 
6. Public engagement and informed public debate is essential to help the public to judge future uses of 
neuroimaging. Without this, there is a risk of damaging the credibility of good uses of imaging and 
public distrust of scientists + medics, as occurred with genetically modified foods, genetic engineering, 
climate change, etc.  
7. Scientists and medics should actively engage with the public to explain their results in an easily 
understandable way, including the limitations and drawbacks of their research. 
8. Society must be able to interpret and apply the results of this research wisely. 
9. There is a need for expert groups to be able to advise lawyers, government, other bodies on forensic 
uses of neuroimaging. This could be achieved through establishment of a “Forensic Science Advisory 
Committee”. 
10. There is a need to establish standards for imaging experts in court or in any other capacity as an expert 
witness. 
11. Experts should be more accessible to the public and to government and other groups who may seek 
their opinions on wider uses of neuroimaging. Providing such advice should not be seen as intrusive or 
an unnecessary demand on time. It is part of the responsibility of the scientist to communicate the 
results of their research to the public and other interested bodies.  
12. A watchdog to monitor and comment on emerging alternative uses of neuroimaging would be valuable 
for society. 
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13. There are, however, some serious safety issues when scanners are operated outside traditional 
scientific/medical settings by users with commercial interests who may be less aware of the potential 
dangers. These range from damage from metallic missiles, to subjects with specific contraindications to 
MR imaging, to the consequences of incidental findings with life threatening significance. 
14. Prohibition of use or over-regulation of use could well impede important scientific progress and in any 
case, generally does not work, and may even backfire and end in ridicule or alienation of those 
proposing the increased regulation. 
15. An enlightened society should encourage good ethical and regulatory frameworks and codes of practice 
so that imaging technologies can benefit society and not fall into disrepute – Scotland first 
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3. Planned Outputs 
The following were planned prior to the programme or developed during the programme as new 
opportunities arose. New opportunities for dissemination are still arising. 
a. Background material and documentation of the workshops 
1. Repository of scientific and media publications on wider uses of neuroimaging;  
2. Transcriptions of all workshops’ individual discussion groups and group feedback on specific topics. 
3. Video recordings of all presentations available on the web (see www.sinapse.ac.uk); 
4. Video recordings of all discussions available in a repository; 
5. Repository of all media coverage of the project 
b. Peer-reviewed publications 
1. Systematic review of non-traditional uses of neuroimaging and their presentation in lay and scientific 
press, comparing attitudes, accuracy of reporting and scientific content; 
2. Paper describing the expert and lay opinions;  
3. Paper describing the process of debate and main conclusions and recommendations arising from the 
workshops. 
4. Paper describing the process of the workshops and key outcomes in SCRIPTed; 
5. Special edition of the journal Cortex, on neuroimaging in society (approx 15-18 short articles reflecting 
topics addressed in the Workshop talks by the speakers with discussion forum for continuing debate) 
6. Special edition of the online journal SCRIPTed – approx 7-10 full articles on topics addressed in 
Workshop talks by the speakers – including article on Campbell Collaboration and importance of 
evidence-based use of neuroimaging and related technologies as forensic evidence. 
7. Church of Scotland report on technologies. 
c. Non-peer reviewed publications about the project 
1. British Neuroscience Association (BNA) paper. 
2. Holyrood Magazine article. 
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d. Spin off projects and other outputs 
1. The material is now part of an ongoing PhD on science and politics (Escobar);  
2. Pilot for doctoral student or post-doc attachment to Parliament (potential focus for future science 
policy studentship funding applications) now under discussion; 
3. Leverhulme Trust grant on science and policy: An application to Leverhulme on the impact of social 
media on science reporting and understanding and their uptake by law and politics, is under 
preparation (BS), which features neuroimaging as one of the there case studies. 
4. Some materials passed to Royal Society to assist with their internal review of emerging uses of 
neuroscience technologies including neuroimaging. 
5. Module on neuroimaging in society in University of Edinburgh online MScs in Neuroimaging for 
Research and in Psychology of Science and Society also available as online Continuing Professional 
Development (CPD) materials for use by members of the imaging and other scientific and medical 
sectors and for public use. 
6. CPD (continuing professional development) materials for SINAPSE students and staff and,  
7. The case studies that were used in Workshop 2 are now integrated in the elective Honours course 
“Evidence Interpretation and Evaluation” for the LLB at Edinburgh University.  
8. Edinburgh Science Festival debate April 2011 
9. Science in Scotland annual meeting 2010 info on SINAPSE stand 
10. Conference presentations – Science and Public (June 2011, O Escobar); European Consortium for Policy 
Research (2011 O Escobar); BNA (2011); BSA; invited talks in York 2011 (JMW); Edinburgh Neuroscience 
Annual Meeting 2011; SINAPSE Annual Meeting 2011; other work ongoing 
e. Specific recommendations 
1. List of “frequently asked questions” to guide the legal profession in forensic uses of neuroimaging for 
SCRIPTed website. 
2. List of recommendations to funding bodies (eg encourage interdisciplinary studentships between law 
and medicine or law and neuroscience; targeted funding calls for research into ethical implications of 
emerging technologies and into improved methods for enhancing public understanding of science). 
3. Recommendation that forensic uses of neuroimaging need to become evidence-based (paper in 
SCRIPTed, PAGS). 
4. That the House of Commons Select Committee report on “Forensic technology on trial” 
recommendation to establish an Advisory Committee on Forensic uses of technology should be 
implemented. 
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f. Taking forward at Government/National level  
1. MSP proposal for a Members Debate in the Chamber of the Parliament,  
2. Presenting the project findings to a subject Committee, eg Health or Justice;  
3. Presenting to the Cross Party Group on Science and Technology; 
4. Presenting to the Scottish Science Advisory Committee (the work has already been presented very 
briefly to the SSAC at the IAS as part of a showcase of IAS). 
5. Science Debate in Parliament (Nov 2010 or 11). 
6. Scottish Law Commission possible topic to consider for legal reform (BS). 
7. Presentation to Scottish government officials  
8. Presentation to Westminster Science and Technology Committee or related (JDW). 
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4. Overall added value of the programme and its potential impact  
This programme had considerable added value. As well as achieving its objectives of giving a thorough 
airing to an important and emerging topic for society, it brought together clinicians and scientists involved 
in neuroimaging, lawyers, ethicists, those involved in the church, policy makers, science funders and, in so 
doing, provided a catalyst for many related activities. It has resulted in several publications – three direct 
(in preparation or about to be submitted at the time of writing) and several others that were not 
anticipated at the start of the project, but which will be valuable in the fields of neuroscience and law 
respectively. It has resulted in opportunities to improve understanding of interactions between media and 
science to improve dissemination of information to the public. It has shown that the public is sceptical of 
media portrayals of many aspects of science, but that there are still serious risks of misleading claims 
damaging the credibility of neuroimaging and raising false hopes. It has provided raised awareness of the 
extent to which neuroimaging is creeping into use in the legal profession, but also provided some options 
to increase interdisciplinary working that may ultimately help to reduce the chances of miscarriages of 
justice. The programme has aroused interest amongst others in other parts of the UK and will inform their 
activities. It has established links with key groups in North America working on similar topics. Perhaps 
Scotland can take a lead role in establishing bodies such as a Forensic Science Advisory Committee that 
would assist the legal system (and clinicians, neuroimaging researchers and neuroscientists) in making the 
best use of powerful new technologies. Perhaps some proactive steps by the neuroscience and medical 
professions to adopt some sensible self regulation would preempt the need for regulation to be imposed by 
other authorities. 
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Appendix 1: Programme activities  
The following agendas summarise the programme activities. The methods used have been summarised 
previously (survey, preparation for each event, methods used to stimulate discussion) and will not be 
repeated here. 
Part 1: Advances in Neuroimaging and the Implications for Society 
Thursday 6th May 2010 
 Introduction and overview of whole programme and Part 1 aims and objectives 
Prof Joanna Wardlaw, SINAPSE and SFC Brain Imaging Research Centre, University of Edinburgh 
(Including a brief resume of different forms of imaging for the non-imaging people in the audience 
Discussion session 1: Imaging – Can imaging reveal the mind in health and disease? 
Chaired by: Prof David Wyper, Director of SINAPSE and Dept of Medical Physics, University of Glasgow 
 Brain Imaging – structural and functional imaging correlates of psychosis and psychopathy 
Prof Stephen Lawrie, Division of Psychiatry, Centre for Clinical Brain Sciences, University of 
Edinburgh 
 Ethical issues raised by uses of neuroscience in law – delivered remotely 
 Prof Walter Sinnott-Armstrong, Kenan Institute for Ethics, Duke University, USA 
  Privacy and governance implications of wider societal uses of brain imaging data 
Dr Hester Ward, Medical Director, NHS Information Services Division 
  Panel Question and Answer Session 
Speakers from first session 
  Discussion Groups 
Group lead discussants - Walter Sinnott-Armstrong/Peter Sandercock, Sergio Della Sala, Mike Nellis, 
Jonathan Cavanagh 
 Feedback from discussions and agreement on main points and points to carry forward 
 Chair: Dr Jane Haley, Edinburgh Neuroscience, University of Edinburgh 
Discussion session 2: Imaging - limitations and restrictions 
Chaired by: Prof Peter Sandercock, Edinburgh Neuroscience, Centre for Clinical Brain Sciences, University of 
Edinburgh 
 Mind reading – can imaging tell what you are thinking? – delivered remotely 
 Prof Andreas Kleinschmidt, Director of Research, INSERM-CEA Cognitive Neuroimaging Unit, 
France 
  Accuracy, reliability and limitations of functional and structural imaging data 
 Dr Daniela Seixas, Dept. of Imaging, Centro Hospitalar de Vila Nova de Gaia, and Faculty of 
Medicine of Porto University, Portugal 
  Panel Question and Answer Session 
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 Speakers from second session 
  Discussion Groups 
 Group lead. Discussants – Roger Staff, Klaus Kessler, Jeremy Hall, Burkhard Schaeffer 
 Feedback from discussions and agreement on main points and points to carry forward 
 Chair: Dr Jonathan Cavanagh, SINAPSE, Dept of Psychiatry, University of Glasgow 
Friday 7th May 2010 
Discussion Session 3: Imaging and Neuroethics 
Chaired by: Dr Alison Murray, SINAPSE, Aberdeen Biomedical Imaging Centre, University of Aberdeen 
 The strength of our claims and the strength of our data - do they always go together? 
 Dr. Klaus Kessler, Centre for Cognitive NeuroImaging, University of Glasgow 
  The role of imaging in neuromarketing – delivered remotely 
 Prof Gemma Calvert, Neurosense and University of Warwick 
  Neuroimaging: a dose of realism 
 Prof Charles Warlow, Centre for Clinical Brain Sciences, University of Edinburgh 
  fMRI in impaired consciousness – Future diagnostic opportunities and ethical challenges 
 Prof Christian Schwarzbauer, SINAPSE, University of Aberdeen 
  Reading our thoughts – the future 
 Dr Lars Muckli, University of Glasgow 
  Panel Question and Answer Session 
 Speakers from third session 
  Discussion Groups 
 Group lead. Discussants – Gemma Calvert/Douglas Potter, Daniela Seixas, Lars Muckli, Murdo 
MacDonald 
 Feedback from discussions and agreement on main points and points to carry forward 
 Chair: Dr Janet De Wilde, SINAPSE Executive Director, Central Admin Office, University of 
Edinburgh 
Discussion Session 4: Summarising and outputs 
  Review draft web questions for public opinion survey 
 Mr Garret O'Connell, Brain Imaging and Society Work Package Co-ordinator 
  Summarising workshop 
 Chairs: Prof Peter Sandercock, Edinburgh Neuroscience, Centre for Clinical Brain Sciences, 
 University of Edinburgh and Prof Joanna Wardlaw, SINAPSE and SFC Brain Imaging Reserach Centre, 
University of Edinburgh 
 
 Discuss and agree outputs 
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Part 2: What is the Legal View? 
(Briefing papers circulated in advance)  
Monday 7th June 2010 
Discussion Session 1: Imaging all the people? Brain Imaging in multi-stakeholder perspective 
Chaired by: Prof Joanna Wardlaw, SINAPSE, University of Edinburgh  
  The view from the start: Best of Part 1, a PowerPoint medley 
 Burkhard Schafer, Co-Director, SCRIPT Centre for IT and IP law, and Joseph Bell Centre for Forensic 
Statistics 
 The view from the Bench 
 Jed Rakoff, United States District Judge for the Southern District of New York 
  The view from the pulpit 
 Murdo MacDonald, Church of Scotland; Church and Society Council 
  Panel Question and Answer Session 
 Speakers from first session 
 Discussion Groups 
 Group lead discussants - Alison Murray Till Vierkant, Peter Sandercock 
 Issues to be discussed: Creating a 'Brain Imaging and Law FAQ list' 
 Feedback from discussions and agreement on main points and points to carry forward 
 Chair: Dr Jane Haley, Edinburgh Neuroscience, University of Edinburgh 
Discussion Session 2: Mind, your own business? 
Chaired by: Burkhard Schafer, SCRIPT, University of Edinburgh  
 Mind reading 
 Prof Hank Greely Director, Center for Law and the Biosciences, Stanford University 
  The truth machine 
 Prof Mike Nellis, Professor of Criminal and Community Justice, University of Glasgow 
  In the Twilight Zone of Privacy Law 
 Judith Rauhofer, University of Central Lancashire 
  Panel Question and Answer Session 
 Speakers from second session 
  Coffee and Discussion Groups 
 Group lead. Discussants - Jed Rakoff, Burkhard Schafer, Joanna Wardlaw, Judith Rauhofer 
 Activity: Analysing a Brain image 
 Feedback from discussions and agreement on main points and points to carry forward 
 Chair: Dr Cyril Pernet, University of Edinburgh 
Public Lecture 
 Neuroscience, Law, and Society - The Coming Revolution 
 Prof Hank Greely, Deane F. and Kate Edelman Johnson Professor of Law, Stanford University and 
Co-Director of the MacArthur Law and Neuroscience Project, USA 
 Lecture Theatre 1, McCance Building, 16 Richmond Street, University of Strathclyde, Glasgow 
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Tuesday 8th June 2010 
Discussion Session 3: Mapping the Landscape of Brain Imaging and the law – beyond crime and 
retribution 
Chaired by: Dr Mike Nellis, University of Glasgow 
  Brain Imaging: Consent Issues, and Licensing of Storage and Analysis 
 Michael Bromby, Glasgow Caledonian University 
  Brain imaging and Insurance law 
 Gerard Porter, SCRIPT, University of Edinburgh 
  Panel Question and Answer Session 
 Speakers from third session 
  Discussion Groups 
 Group lead. Discussants - Klaus Kessler, Martin Pickersgill,  
 Issues to be discussed: Drawing a conceptual map of Brain Imaging and the Law; Identifying 
training and teaching needs 
 Feedback from discussions and agreement on main points and points to carry forward 
 Chair: Dr Janet De Wilde, SINAPSE, Central Administration Office, University of Edinburgh 
Discussion Session 4: A fine mess you got us into – Brain Imaging and the notion of responsibility  
Chaired by: James Chalmers, University of Edinburgh 
  Brain Imaging and responsibility in criminal law - to be delivered by Burkhard Schafer 
 Hans Markowitsch, Prof for Physiological Psychology, Bielefeld 
 Brain imaging, philosophy and the criminal law 
 Till Vierkant, Depertment of Philosophy, University of Edinburgh  
 Panel Question and Answer Session 
 Speakers from fourth session 
  Discussion Groups 
 Group lead. Discussants - Hank Greely, David Shaw, Michael Bromby, 
 Issues to be discussed: “Dear First Minister”… Requests and suggestions for politics and 
governments 
  Feedback from discussions and agreement on main points and points to carry forward 
 Chair: Burkhard Schafer, SCRIPT, University of Edinburgh 
  Round up of Conference: Lessons learned, road ahead. 
Part 3, A: Public Engagement Discussion 
Friday 25th June 2010 
 Welcome and Introduction  
 Robert Rae, Director Scotland’s Future Forums  
  Brain Imaging: What is it all about? Includes short Q & A session 
 Prof Peter Sandercock, Centre for Clinical Brain Sciences, University of Edinburgh  
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  Group Work 1 – What do we all make of it? 
Questions: What do you think of Brain Imaging? 2 How do you think the science could and should 
be used in the future? 
 Future Perspective: Brain Imaging in the year 2025 
 Robert Rae, Director Scotland’s Future Forums 
  Case Studies from the Future 
Medical: Its 2025, and you are applying for life insurance. The insurance company insist that to 
qualify for a preferable premium, you have to have a brain image. This may show whether you are 
likely to develop dementia later in life. 
- Is it right that the Insurance company can ask you to have this done? 
- Should the Insurance company tell you what the scan shows? 
- What should politicians and other do in the short and medium term to avoid/ develop this use of 
brain imaging technology? 
Security: It’s 2025, you are going on holiday. When you arrive at the airport you are asked to have 
a brain image as part of the “check-in” procedure. This image will be cross referred to a central 
intelligence computer to ascertain if you have any criminal intentions in your mind. 
- Is it right that you have to go through this scan before you board a flight? 
- What does the use of this technology mean for civil and human rights? 
- What should politicians and other do in the short and medium term to avoid/ develop this use of 
brain imaging technology? 
Commerce: It’s 2025, a market research company has just undertaken its first brain imaging 
survey of 1000 consumers to ascertain what their “true” consumer desire are.  This information is 
being used to develop the company’s mass marketing strategy based on the research gathered.  
- Is it right that commercial companies can use brain imaging as a research tool in this way? 
- What does the use of brain imaging technology in this way mean for consumer rights / consumer 
choice? 
- What should politicians and other do in the short and medium term to avoid/ develop this use of 
brain imaging technology? 
It’s 2025, and you have applied for a new job. The companies HR department have insisted you 
undertake a brain imaging procedure. This may show whether you have embellished your cv or 
have lied at interview 
- Is it right that the company will be able to use brain imaging technology in this way? 
- What will using this technology mean for your civil/employment rights and business more 
generally? 
- What should politicians and other do in the short and medium term to avoid/ develop this use of 
brain imaging technology? 
 
Law: It’s 2025 and your son / daughter has suffered a stroke following a physical attack by a 
neighbour. The perpetrator’s legal team have suggested that the person may be suffering from 
early schizophrenia and request a brain scan. The scan is inconclusive but the scan shows a 
shrinkage of the brain which may be down to the early onset of schizophrenia or may be down to 
excessive alcohol use. 
- Should a brain image be used in the court case? 
- What affect might this “evidence’ have on the jury? 
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- What should politicians and other do in the short and medium term to avoid/ develop this use of 
brain imaging technology? 
  Presentations by groups on their case studies 
  Next Steps and Close 
Part 3,  B. Policy Makers 
(Briefing papers circulated in advance; results of public and expert survey made available) 
Thursday 19th August 
Welcome 
Robert Rae, Scotland's Futures Forum 
Summary of debate 1: Neuroimaging in Society 
Prof Joanna Wardlaw, Scottish Imaging Network - A Platform for Scientific Excellence (SINAPSE) and 
University of Edinburgh 
Summary of debate 2: What is the Legal View? 
Burkhard Schafer, SCRIPT and University of Edinburgh 
Group discussions - discuss ethical questions suggested by Prof Jonathan Moreno 
Facilitated by Professor Jonathan Moreno, David and Lyn Silfen University Professor of Ethics and 
Professor of Medical Ethics and of History and Sociology of Science at University of Pennsylvania 
and Center for American Progress, Washington, USA 
Whole room feedback at the end  
Report of results of the public and expert online survey's: Seeking opinions on the use of brain 
imaging technology in society 
Dr Jane Haley, Edinburgh Neuroscience, University of Edinburgh 
Society and the Reception of Technology: the American Experience 
Prof Jonathan Moreno, Professor of Medical Ethics, University of Pennsylvania and Center for 
American Progress, USA 
followed by a short question and answer session 
Group discussions - How might the American experience relate to Scotland? 
Followed by whole room feedback 
Reflections on the implications for Scottish policymakers 
Prof Anne Glover, Chief Scientific Advisor, Scotland 
Whole room Feedback - What would we like to say to our politicians? 
Chaired by Prof Anne Glover and Prof Jonathan Moreno  
Next Steps and Closing remarks 
Robert Rae, Scotland's Futures Forum 
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Appendix 2: List of participants 
Organizers 
Joanna Wardlaw, SINAPSE and Edinburgh Neuroscience, University of Edinburgh  
Peter Sandercock, SINAPSE and Edinburgh Neuroscience, University of Edinburgh  
Janet de Wilde, SINAPSE Central Administration Office   
Jane Haley, Edinburgh Neuroscience, University of Edinburgh 
Burkhard Schafer, Script, University of Edinburgh and Joseph Bell Institute for Forensic Statistics  
Robert Rae, Scotland’s Futures Forum 
Donald Jarvie, Scotland’s Futures Forum  
Jane Morgan, Scottish Universities Insight Institute (formerly Institute for Advanced Studies), University of 
Strathclyde  
Part 1 Participants 
Matt Adamson, Law Student, University of Edinburgh, UK 
Gemma Calvert, Neurosense Limited and Applied Neuroimaging Group, University of Warwick, UK 
(Speaker) 
Jonathan Cavanagh, Department of Psychiatry, University of Glasgow, UK (Chair) 
Neil Dawson, PsyRING and University of Strathclyde, UK 
Sergio Della Sala, Department of Psychology, Edinburgh Neuroscience, University of Edinburgh, UK (Chair) 
Oliver Escobar, Queen Margaret University, Edinburgh, UK (Scribe) 
Madeleine Grealy, Department of Psychology, University of Strathclyde, UK  
Jeremy Hall, Division of Psychiatry, Edinburgh Neuroscience, University of Edinburgh, UK 
Harriet Johnson, University of St Andrews, UK (Scribe) 
Klaus Kessler, Centre for Cognitive Imaging, University of Glasgow, UK (Speaker) 
Andreas Kleinschmidt, Director of Research, INSERM-CEA Cognitive Neuroimaging Unit, France (Speaker) 
Stephen Lawrie, Division of Psychiatry, Edinburgh Neuroscience, University of Edinburgh and Scottish 
Mental Health Research Network, UK (Speaker) 
Murdo MacDonald, Society, Religion and Technology Project, Church of Scotland, UK 
Calum Mackellar, Scottish Council on Human Bioethics and Society and Church of Scotland, UK 
Lars Muckli, Centre for Cognitive Imaging, University of Glasgow, UK (Speaker) 
Alison Murray, SINAPSE and Aberdeen Biomedical Imaging Centre, University of Aberdeen (Chair) 
Mike Nellis, Glasgow School of Social Work, University of Strathclyde (Chair) 
Garrett O'Connell, Division of Psychiatry, University of Edinburgh (Report co-ordinator) 
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Cyril Pernet, SFC Brain Imaging Centre, Edinburgh Neuroscience, University of Edinburgh, UK 
Douglas Potter, Psychology, University of Dundee, UK 
Judith Pratt, PsyRING and University of Strathclyde, UK 
Stephanie Schorre, Law student, University of Edinburgh, UK 
Christian Schwarzbauer, SINAPSE and Biomedical Imaging Centre, University of Aberdeen, UK (Speaker) 
Kirsten Shuler, Division of Clinical Neurosciences, University of Edinburgh, UK (Scribe) 
David Shaw, Dental School, University of Glasgow, UK 
Walter Sinnott-Armstrong, Department of Philosophy and the Kenan Institute for Ethics, Duke University 
and Co-Director MacArthur Law and Neuroscience Project, USA (Speaker) 
Roger Staff, Department of Biomedical Physics, University of Aberdeen, UK 
Daniela Seixas, Dept. of Imaging, Centro Hospitalar de Vila Nova de Gaia, and Faculty of Medicine of Porto 
University, Portugal (Speaker) 
Till Vierkant, Philosophy, University of Edinburgh, UK 
Glenn Walker, Religion and Technology Project, Church of Scotland, UK 
Hester Ward, Medical Director Information Services Division, NHS National Services, UK (Speaker) 
Charles Warlow, Centre for Clinical Brain Sciences, Edinburgh Neuroscience, University of Edinburgh, UK, 
(Speaker) 
David Wyper, University of Glasgow and Director of SINAPSE, UK 
Part 2 Participants 
Matt Adamson, School of Law, University of Edinburgh, UK 
Christopher Bechtel, Society, Religion and Technology Project , Church of Scotland, UK 
Michael Bromby, School of Law and Social Sciences, Glasgow Caledonian University, UK (Speaker) 
James Chalmers, School of Law, University of Edinburgh, UK (Chair) 
Pei Ting Chou, School of Law, University of Edinburgh, UK  
Oliver Escobar, Queen Margaret University, Edinburgh , UK (Scribe) 
Hank Greely, Center for Law and Biosciences, Stanford University, USA (Speaker) 
Chris Lever, School of Law, University of Edinburgh, UK  
Murdo MacDonald, Society, Religion and Technology Project, Church of Scotland, UK (Speaker) 
Hans Markowitsch, Department of Psychology, University of Bielefeld, Germany (Speaker, talk delivered by 
Burkhard Schafer) 
Angela Mathis, ThinkTank Maths Limited, Scottish Scientific Advisory Committee, UK 
Cyrille Mathis, France 
Alison Murray, SINAPSE and Aberdeen Biomedical Imaging Centre, University of Aberdeen, UK 
Shaun Murray, University of Edinburgh, UK (Scribe) 
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Mike Nellis, Glasgow School of Social Work, Strathclyde University, UK (Speaker and Chair) 
Garrett O'Connell, Division of Psychiatry, University of Edinburgh, UK (Report co-ordinator) 
Cyril Pernet, SINAPSE, University of Edinburgh, UK  
Martin Pickersgill, Social Science, University of Edinburgh, UK 
Gerard Porter, School of Law, University of Edinburgh, UK (Speaker) 
Emily Postan, LLM Innovation, Technology and the Law, University of Edinburgh, UK  
Jed Rakoff, Judge, Southern District of New York, USA (Speaker) 
Judith Rauhofer, Centre for Law, Information & Converging Technologies, University of Central Lancashire, 
UK (Speaker)  
Stephanie Schorre, School of Law, University of Edinburgh, UK 
Sinclair Scott, Society, Religion and Technology Project, Church of Scotland, UK  
David Shaw, Dental School, University of Glasgow, UK 
Kirsten Shuler, Division of Clinical Neurosciences, University of Edinburgh, UK (Scribe) 
Joanna Simpson, University of Stirling, UK (Scribe) 
Till Vierkant, Department of Philosophy, University of Edinburgh, UK (Speaker) 
David Wyper, University of Glasgow and Director of SINAPSE, UK 
Part 3A: Members of the Public Participants 
Pat Abel  
Simon Bradstreet, Network Director, Scottish Recovery Network  
 Joyce Armstrong 
Bryan Beattie, Creative Services 
Linda Boyes, ACOSVO  
Shona Craven 
Bob Crawford 
Paola Di Maio 
June Edgar 




Frances Gallagher, Deputy chair of RSA Scotland 
David Harvey 
John Hughan, Acute Capital Planning Manager, NHS 
Brain Imaging: Programme Report 
33 
 
Derek Kelter, Convenor, Inclusion Scotland 
Shona Maciver, Director, Locofoco Limited 
Calum MacKellar, Director of Research, Scottish Council on Human Bioethics 
Carol Malcolm, Inward Investment Specialist 
Scottish Enterprise 
John McCafferty 
Catherine McCall, University of Strathclyde 
Stephen McCue  
Marcus McCullough 
Agnes McGroarty 
Brian McKechnie, Scottish Centre for Intergenerational Practice 
Derek Mills 
Sheila Richmond, Secretary- Scottish Borders Elder Voice 
Morven Shearer, Neuroscientist, St Andrews University 
Alex Smith, Enterprising Solutions (Kirkintilloch) 




Giles Wheatley, Cowal Council on Alcohol & Drugs 
Part 3. B. Policy Makers Participants 
Joyce Armstrong 
Fiona Bisset, Senior Medical Officer/ Consultant in Public Health Medicine, Directorate of Health and 
Wellbeing 
Jonathan Cavanagh, SINAPSE, Dept of Psychiatry, University of Glasgow, UK 
Oliver Escobar , Queen Margaret University, Edinburgh, UK (Scribe) 
Anne Glover, Chief Scientist Scotland, Science Advisory Council, UK (Speaker) 
Michele Hipwell, Which 
Klaus Kessler, University of Glasgow, UK 
Murdo Macdonald, Church of Scotland, UK 
Angela Mathis, Science Advisory Council; CEO of ThinkTankMaths, International Technology 
Commercialization, UK 
Cyrille Mathis, France 




Elizabeth McKenzie, Health Psychology, Queen Margaret University 
Sarah Mee, The Royal Society, London, UK 
Jonathan Moreno, Department of History and Sociology of Science, University of Pennsylvania also Center 
for American Progress, Washington, DC, USA (Speaker) 
Lars Muckli , University of Glasgow, UK 
Ann Packard, RSA 
Martin Pickersgill, Social Sciences, University of Edinburgh, UK  
Christian Schwarzbauer, University of Aberdeen, UK 




David Wyper, University of Glasgow and Director of SINAPSE, UK 
Part 3 C. Meeting with MSPs, Holyrood, 29th Sept 2010 
Michael Bromby, School of Law and Social Sciences, Glasgow Caledonian University, UK 
Janet De Wilde, SINAPSE 
Helen Eadie, Health and Sport Committee 
Murray Earle, Senior Research Specialist, SPICE 
Oliver Escobar, University of Edinburgh, UK 
Jane Haley, Edinburgh Neuroscience University of Edinburgh 
Simon Hettle 
Donald Jarvie, Scotland’s Futures Forum, UK 
Cyrille Mathis, Scottish Science Advisory Council  
Angela Mathis, Scottish Science Advisory Council  
Murdo McDonald, Society, Religion and Technology Project, Church of Scotland, UK 
Des McNulty 
Jane Morgan, Scottish Universities Insight Institute, UK 
Douglas Potter, Psychology, University of Dundee, UK  
Robert Rae, Scotland’s Futures Forum, UK 
Hannu Rajaniemi, Scottish Science Advisory Council, UK 
Beverly Roberts, Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, UK 
Burkhard Schafer, School of Law, University of Edinburgh, UK 
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Emma Sprooten, University of Edinburgh 
Roger Staff, University of Edinburgh, UK 
Stephen Lawrie, Division of Psychiatry, University of Edinburgh, UK 
Eric Swanepoel, Office Manager/Researcher for Dr Bill Wilson MSP, Deputy Convener of the CPG on Science 
and Technology, Scottish Parliament, UK 
Joanna Wardlaw, SFC Brain Imaging Centre, University of Edinburgh and SINAPSE, UK 
David Wyper, University of Glasgow and Director of SINAPSE, UK 
